Abstract:In most immune responses including transplant rejection, T effector cells always outnumber and outperform Tregs, and therefore means to deplete T effector cells is critical to tolerance induction. T cell apoptosis is known to be permissive to allograft tolerance, but how apoptosis of T effector cells (when and by what degree) affects the induction of Tregs in allograft tolerance remains incompletely defined. In the present study we addressed the interplay of T effector cells and Tregs both in vitro and in vivo and how such interplay impacts transplant tolerance. We found in an in vitro system that activation of T effector cells led to rapid production and consumption of IL-2, which resulted in robust effector cell proliferation in an autocrine fashion. However, presence of Foxp3+Tregs in the same culture allowed CD4+ T effector cells to produce IL-2 but unable to consume IL-2 (lack of STAT5 phosphorylation), and Tregs became the sole cell type in the culture that could use IL-2 in a paracrine fashion (strong STAT5 phosphorylation). In this setting, survival and expansion of Tregs is dependent on survival of IL-2 producing T effector cells, and the degree of Treg proliferation is contingent on levels of IL-2 from T effector cells. Strikingly, addition of Rapamycin in the culture readily induced apoptotic cell death of T effector cells, which resulted in subsequent death of Tregs due to cessation of IL-2 production (death by starvation). Interestingly, inclusion of IL-15 failed to rescue Tregs in spite of the finding that IL-15 also triggered STAT5 activation. Thus, early and massive apoptosis of T effector cells antagonized Tregs unless exogenous IL-2 is provided. In a skin transplant model, we found that Rapamycin alone showed minimal effects in prolonging skin allograft survival, but Rapamycin and IL-2 together markedly extended skin allograft survival (>40 days). Our data demonstrated new mechanistic insights on the interdependence and antagonistic effects of Tregs and T effector cells, and uncovered new aspects where IL-2 works the best in tolerance induction. These new findings may have important clinical implications.

Regulatory T-Cell Counter-Regulation by Innate Immunity Is a Barrier to Transplantation Tolerance

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Regulatory T cells and transplantation tolerance.

Promotion of Allograft Survival by CD4+CD25+ Regulatory T Cells: Evidence for in Vivo Inhibition of Effector Cell Proliferation

Transplant Tolerance Depends on Regulatory T Cells Induced by TGF-β-producing Regulatory B Cells (P2168)

Regulatory T Cells in Transplantation Tolerance

Regulatory-B Cell and Regulatory-T Cell Collaborate to Promote Transplantation Tolerance (126.2)

Generation of adaptive regulatory T cells by alloantigen is required for some but not all transplant tolerance protocols.

T Regulatory Cells As an Immunotherapy for Transplantation

Regulating Regulatory T Cells to Achieve Transplant Tolerance.

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

T regulatory cells as an immunotherapy for transplantation.

New Insights on T Cell Apoptosis in the Induction of Treg-Dependent Dominant Tolerance

GITR Blockade Facilitates Treg Mediated Allograft Survival

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

An Unexpected Counter‐Regulatory Role of IL‐10 in B‐Lymphocyte‐Mediated Transplantation Tolerance

Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings

Tgf-B-Producing Regulatory B Cells Induce Regulatory T Cells and Promote Transplantation Tolerance.

In Vivo Environment Necessary to Support Transplanted Donor Mouse T Regulatory Cells